Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 12 September

Bell Direct
September 12, 2024

8 minutes with 8 executives

Bell Direct
September 11, 2024

Morning Bell 11 September

Bell Direct
September 11, 2024

Morning Bell 10 September

Bell Direct
September 10, 2024

Morning Bell 9 September

Bell Direct
September 9, 2024

Weekly Wrap 6 September

Bell Direct
September 6, 2024

Morning Bell 5 September

Sam Kanaan
September 5, 2024

Morning Bell 4 September

Bell Direct
September 4, 2024

Morning Bell 3 September

Bell Direct
September 3, 2024

Morning Bell 2 September

Bell Direct
September 2, 2024

Weekly Wrap 30 August

Bell Direct
August 30, 2024

Morning Bell 30 August

Bell Direct
August 30, 2024